PROCEPT BioRobotics

$36.89 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About PROCEPT BioRobotics

PROCEPT BioRobotics Corporation is a United States-based surgical robotics company. The Company enables patient care by developing transformative solutions in urology. The Company has developed Aquablation therapy for the treatment of benign prostatic hyperplasia (BPH). It has developed a surgical robot, Aquabeam that provides autonomous tissue removal from enlarged prostate to treat BPH. Aquabeam provides multi-dimensional imaging, personalized treatment planning, and heat-free waterjet with autonomous robotic execution.

Stock Analysis

last close $37.67
1-mo return 5.1%
3-mo return 73%
avg daily vol. 340.36T
52-week high 47.73
52-week low 15.38
market cap. $1.6B
forward pe -
annual div. -
roe -145.5%
ltg forecast -
dividend yield -
annual rev. $34M
inst own. 69.7%

Subscribe now for daily local and international financial news